About Us

History

1991 Takiron Co., Ltd. launched its medical division to be prepared for manufacturing and distributing medical devices.  
1993 Manufacturing plant was completed at Takiron Co., Ltd. Yasutomi Factory to produce and distributing bioresorbable materials for osteosynthesis.
1994 Gained permission to manufacture medical device.
To manufacture FIXSORB as a bioresorbable material for osteosynthesis was approved.
The sales of FIXSORB started in the field of orthopedic.
1997 Manufacturing FIXSORB MX mini-plate system as a bioresorbable material for osteosynthesis was approved.
The sales of FIXSORB MX started in the fields of oral and maxillofacial/plastic and reconstructive.
1999 ISO 9001 certification was approved.
The sales of FIXSORB MX started in the field of neurosurgery.
 
2000 FIXSORB and FIXSORB MX were approved in China.
The sales of FIXSORB rib/sternum pins started in the field of thoracic surgeries.
 
2001 The second manufacturing plant was completed at Takiron Co., Ltd. Yasutomi Factory.  
2002 EN ISO 13485 certification was approved.
We expanded to overseas market and the sales of FIXSORB started in China.
 
2003 Manufacturing Super FIXSORB 30 as a bioresorbable material for osteosynthesis was approved.
Sales started in the field of orthopedic.
2004 The sales of Super FIXSORB 30 rib/sternum pins started in the field of thoracic surgery.  
2005 Gained permission to manufacture and distribute Class 1 medical device.
CE marking certificate for OSTEOTRANS-OT and OSTEOTRANS-MX (overseas trade names) as bioactive materials for osteosynthesis was approved.
European office opened in Dusseldorf, Germany.
 
2006 Manufacturing and distributing Super FIXSORB MX30/MX40 as bioactive bioresorbable material for osteosynthesis was approved, and sales started in the field of oral and maxillofacial.
Medical Institute was established in Kobe City Port Island.
2007 The sales of “Super FIXSORB 30” interference screw started in the field of sports medicine.
OSTEOTRANS-OT was launched in Europe.
FIXSORB MX was launched in China.
2008 OSTEOTRANS-OT interference screw was launched in Europe.  
2009 The sales of Super FIXSORB MX30/MX40 started in the field of neurosurgery.  
2011 European office moved to Berlin, Germany.  
2013 OSTEOTRANS-MX was launched in Republic of Korea and Southeast Asia.  
2014 European office returned to Dusseldorf, Germany
ISO 13485 certification was approved.
 
2016 European office was closed.  
2017 Teijin Limited took over the medical division of C.I. Takiron Co., Ltd.’s, and established Teijin Medical Technologies Co., Ltd. opening Osaka headquarter and Tokyo Sales Office.
Unified quality assurance standards into ISO 13485.
2018 Medical Institute moved to Okayama from Kobe.
2019 Manufacturing and Distributing Super FIXSORB EX as abioresorbable material for osteosynthesis was approved, and the sales started in the field of oral and maxillofacial.
2020 The sales of Super FIXSORB EX started in the field of neurosurgery.